Search results
CVS COVID-19 Vaccine Near Columbus OH
www.cvs.comPharmacy LocationBy appointment only1515 West Broad Street(614) 274-16203355 East Livingston Avenue(614) 237-37373100 Cleveland Avenue(614) 263-09232929 Stelzer Road(614) 337-62106030 N Hamilton Rd(614) 245-6033759 Neil Avenue(614) 224-92752160 North High Street(614) 294-2105Sputnik V (Russian: Спутник V, the brand name from the Russian Direct Investment Fund or RDIF) or Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in ...
- Gam-COVID-Vac, Гам-КОВИД-Вак
- SARS-CoV-2
The COVID-19 vaccination campaign in Russia is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
- 5 December 2020 – present
- COVID-19 pandemic in Russia
- Immunization against COVID-19
- Russia
Feb 2, 2021 · Russia's Sputnik V coronavirus vaccine gives around 92% protection against Covid-19, late stage trial results published in The Lancet reveal. It has also been deemed to be safe - and...
Jul 27, 2021 · Growing evidence suggests Russia’s Sputnik V COVID vaccine is safe and very effective. But questions about the data remain. Published: July 27, 2021 3:55pm EDT. Russia was the first country...
Aug. 11 President Vladimir V. Putin announces that a Russian health care regulator had approved the vaccine, renamed Sputnik V, before Phase 3 trials had even begun. Vaccine experts decry the...
Jul 6, 2021 · Russia’s vaccine is in use in nearly 70 nations, but its adoption has been slowed by controversies and questions over rare side effects, and it has yet to garner World Health Organization...
Nov 28, 2020 · Russia's vaccine has 91.4 per cent efficacy from an analysis of more than 18,000 people, said a release on the Sputnik V website. The vaccine's efficacy rose to 95 per cent after 42 days.
